Screening for glucose perturbations and risk factor management in dysglycemic patients with coronary artery disease—A persistent challenge in need of substantial improvement: A report from ESC EORP EUROASPIRE V
Diabetes Care Mar 02, 2020
Ferrannini G, de Bacquer D, De Backer G, et al. – Because dysglycemia is common in patients with coronary artery disease (CAD) and is associated with an unfavorable prognosis, researchers conducted a European survey to examine dysglycemia screening and risk factor management of individuals with CAD in relation to standards of European guidelines for cardiovascular patients. Study participants included 8,261 CAD patients (aged 18 to 80 years) from 27 countries. In total, 2,452 patients had known diabetes. After screening, the incidence of dysglycemia nearly doubled from that self-reported to the true proportion. Only about one-third of all coronary patients had complete normal metabolism of glucose. The researchers suggested that urgent action is needed for both screening and management of CAD and dysglycemia patients, in anticipation of a significant reduction in the risk of further cardiovascular events, diabetes complications, and longer life expectancy.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries